Asset Allocation

As of August 31, 2026.
Type % Net
Cash 8.83%
Stock 66.05%
Bond 25.12%
Convertible 0.00%
Preferred 0.00%
Other 0.00%
View Asset Allocation
Start Trial

Market Capitalization

As of August 31, 2026
Large 80.18%
Mid 15.22%
Small 4.60%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 86.05%    % Emerging Markets: 5.12%    % Unidentified Markets: 8.83%

Americas 65.26%
61.94%
Canada 2.75%
United States 59.19%
3.32%
Chile 1.71%
Mexico 1.61%
As of August 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 15.98%
United Kingdom 6.20%
9.78%
Denmark 0.65%
France 1.68%
Ireland 2.51%
Italy 1.29%
Netherlands 0.88%
Spain 0.67%
Switzerland 2.11%
0.00%
0.00%
Greater Asia 9.93%
Japan 2.11%
3.93%
Australia 3.93%
3.89%
South Korea 1.46%
Taiwan 2.43%
0.00%
Unidentified Region 8.83%

Bond Credit Quality Exposure

AAA 7.99%
AA 41.04%
A 20.96%
BBB 29.56%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.45%
Not Available 0.00%
Short Term 0.00%
As of August 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
37.28%
Materials
16.82%
Consumer Discretionary
7.29%
Financials
10.77%
Real Estate
2.40%
Sensitive
45.52%
Communication Services
7.17%
Energy
0.00%
Industrials
12.16%
Information Technology
26.19%
Defensive
17.20%
Consumer Staples
5.11%
Health Care
8.38%
Utilities
3.72%
Not Classified
0.00%
Non Classified Equity
0.00%
As of August 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of August 31, 2026
Type % Net
Government 30.28%
Corporate 47.75%
Securitized 0.00%
Municipal 18.46%
Other 3.51%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
4.29%
Less than 1 Year
4.29%
Intermediate
39.22%
1 to 3 Years
7.40%
3 to 5 Years
20.20%
5 to 10 Years
11.62%
Long Term
56.49%
10 to 20 Years
20.03%
20 to 30 Years
24.01%
Over 30 Years
12.46%
Other
0.00%
As of August 31, 2026
View Bond Maturity Exposure
Start Trial